We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > PAREXEL

News List

PAREXEL, CHA to enhance early phase clinical research in Korea biospectrumasia
March 15, 2018
Collaboration combines best-in-class offerings from CHA and PAREXEL to enhance early phase clinical trials in growing hub for drug development.
PAREXEL and CHA Medical Group Partner to Enhance Early Phase Clinical Research in Korea biospace
March 14, 2018
PAREXEL International Corporation today announced an alliance with CHA Medical Group (CHA) to enhance early phase clinical development in Korea.
Parexel to go private in $5bn deal pharmatimes
June 23, 2017
Parexel International is being snapped up by private equity group Pamplona Capital Management in a deal valued at around $5 billion, including debt, marking further consolidation of the contract research sector.

Previous page 1 2 3 Next page